Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Microbiology (Reading, England)|April 1, 2008
Characterization of two in vivo-expressed methyltransferases of the Mycobacterium tuberculosis complex: antigenicity and genetic regulationPaul Golby, Javier Nunez, Paul J Cockle, et al.
Vaccine|September 25, 2017
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™Navin Venkatraman, Nicholas Anagnostou, Carly Bliss, et al.
AIDS (London, England)|November 21, 2002
Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cellsAnn L N Chapman, Mwansa Munkanta, Katalin A Wilkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA allelesHomayoun Shams, Peter Klucar, Steven E Weis, et al.
Human Vaccines|January 12, 2010
Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.
The Lancet. Microbe|July 3, 2026
Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA StudyKelvin M Kimenyi, Richard Morter, Diana Nyabundi, et al.
Vaccines|August 28, 2021
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)Chris Butler, Chris Ellis, Pedro M Folegatti, et al.
NPJ Vaccines|July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adultsBorimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Science Translational Medicine|May 8, 2015
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adultsCaroline Ogwang, Domtila Kimani, Nick J Edwards, et al.
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
Pageof 4